RecruitingNot applicableNCT06935578
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
Studying Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Principal Investigator
- Anna Bersano, MD
- Enrollment
- 500 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (17)
- Ospedale Regionale Generale "F. Miulli", Acquaviva delle Fonti, Acquaviva delle Fonti, BA, Italy
- ASST Melegnano Martesana, Melegnano, MI, Italy
- Neurologia Stroke Unit dell'Asst Rhodense, Rho, Mi, Italy
- Fondazione Istituto G. Giglio, Cefalù, Cefalù, PA, Italy
- UO Neurologia degli Ospedali di Cesena e Forlì, Ospedale Bufalini Cesena ed Ospedale Morgagni-Pierantoni (Ausl della Romagna), Cesena, Italy
- ASST di Cremona, Cremona, Italy
- Ospedale "Spaziani" di Frosinone, Frosinone, Italy
- U.O. Neurologia, Ospedale Sant'Andrea, La Spezia, La Spezia, Italy
- ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Ospedale Luigi Sacco, ASST Fatebenefratelli Sacco, Milan, Italy
- Stroke Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
- IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
- Neurologia d'Urgenza e Stroke Unit dell'Ospedale di Pescara, Pescara, Italy
- Neurologia dell'Ospedale Sandro Pertini - ASL Roma2, Roma, Italy
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06935578 on ClinicalTrials.govOther trials for Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT05755997CERebrolysin In CADASILEver Neuro Pharma GmbH
- RECRUITINGNCT06148051AusCADASIL: An Australian Cohort of CADASILPerminder Sachdev
- RECRUITINGNCT06938100Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASILFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGNCT05072483Natural History Study of CADASILNational Heart, Lung, and Blood Institute (NHLBI)